XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets, Net
9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets, Net Goodwill and Other Intangible Assets, Net
The carrying amount of goodwill was $51.7 million at both September 30, 2023 and December 31, 2022.
The gross carrying amount, accumulated amortization and net book value of intangible assets at the end of each period were as follows:
September 30, 2023December 31, 2022
(in millions)
Gross
Carrying Amount
Accumulated AmortizationNet
Book Value
Gross
Carrying Amount
Accumulated AmortizationNet
Book Value
Customer relationships$43.2 $(30.0)$13.2 $43.2 $(27.5)$15.7 
Internal-use software41.3 (13.5)27.8 34.8 (12.0)22.8 
Developed technology27.4 (2.5)24.9 27.4 (1.0)26.4 
Patents36.2 (2.6)33.6 11.0 (0.4)10.6 
Total intangible assets$148.1 $(48.6)$99.5 $116.4 $(40.9)$75.5 
Amortization expense for intangible assets was $2.6 million and $1.9 million for the three months ended September 30, 2023 and 2022, respectively, and was $7.7 million and $5.4 million for the nine months ended September 30, 2023 and 2022, respectively.
In February 2023, the Company paid Bigfoot Biomedical, Inc. $25.1 million, including transaction costs, to acquire patent assets related to pump-based automated insulin delivery technologies. The acquired patent assets have a useful life of 11 years.